What the source establishes
Researchers randomized 365 men with substantial aortic-valve calcification to MK-7 plus vitamin D or placebo. The main outcome was change in the valve’s CT calcification score over two years. [1]
Calcification progressed similarly in both groups. Valve-function measures and reported clinical-event comparisons did not significantly differ, although an inactive matrix-Gla-protein marker decreased with supplementation. [1]
What it does not establish
The combination and selected male population define the scope. The biomarker response cannot be substituted for the negative primary outcome or generalized into proven reversal of valve disease. Funding and conflicts were not established from the abstract. [1]
A hypothetical distinction
Imagine a proposed pathway responds to treatment but the main structural outcome does not. The pathway result shows biological activity, not success on the original clinical question.
| Detail | Interpretation |
|---|---|
| Combined vitamins | Intervention tested |
| Valve calcification | Primary result negative |
| Protein marker | Changed separately |
Sources for this article
- Vitamin K2 and D in Patients With Aortic Valve Calcification: A Randomized Double-Blinded Clinical Trial - PubMed
Source consulted: 2026-09-19. This is a reference resource, not a claim that we conducted the studies or tested a product.